Patents by Inventor Jessica Leigh OCHOA

Jessica Leigh OCHOA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF
    Publication number: 20240158339
    Abstract: Tyramine containing hydroxycinnamic acid amide derivatives are provided as are methods of using the same in modulating metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Application
    Filed: January 22, 2024
    Publication date: May 16, 2024
    Inventors: Lee Heil Chae, Jessica Leigh Ochoa, Dennis Solas
  • EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR ENRICHING BIOACTIVE METABOLITE IN AN EXTRACT
    Publication number: 20230354864
    Abstract: This disclosure relates to methods and compositions with enhanced levels of one or more tyramine containing hydroxycinnamic acid amides. Also disclosed herein are methods for producing a consumable product with enhanced levels of a tyramine containing hydroxycinnamic acid amide. Some embodiments relate to a composition enriched with a tyramine containing hydroxycinnamic acid.
    Type: Application
    Filed: May 12, 2023
    Publication date: November 9, 2023
    Inventors: Lee Heil Chae, James Flatt, Alexandra Marcela Herrmann, Gabriel Navarro, Jessica Leigh Ochoa
  • Extract, consumable product and method for enriching bioactive metabolite in an extract
    Patent number: 11647776
    Abstract: This disclosure relates to methods and compositions with enhanced levels of one or more tyramine containing hydroxycinnamic acid amides. Also disclosed herein are methods for producing a consumable product with enhanced levels of a tyramine containing hydroxycinnamic acid amide. Some embodiments relate to a composition enriched with a tyramine containing hydroxycinnamic acid.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: May 16, 2023
    Assignee: Brightseed, Inc.
    Inventors: Lee Heil Chae, James Flatt, Alexandra Marcela Herrmann, Gabriel Navarro, Jessica Leigh Ochoa
  • RECOMBINANT CELL, EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR PRODUCTION OF BIOACTIVE PLANT METABOLITE
    Publication number: 20220251614
    Abstract: Disclosed herein are recombinant host cells and methods capable of producing a tyramine containing hydroxycinnamic acid amide compounds, derivatives and extracts. Some embodiments provided include, for example, consumable products containing the tyramine containing hydroxycinnamic acid amide produced by the recombinant host cells. Some embodiments provided herein are methods for producing a tyramine containing hydroxycinnamic acid amide or hydroxycinnamic acid amide derivative.
    Type: Application
    Filed: April 22, 2022
    Publication date: August 11, 2022
    Inventors: James Flatt, Chuan Wang, Jessica Leigh Ochoa, Cliff Rutt
  • EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR ENRICHING BIOACTIVE METABOLITE IN AN EXTRACT
    Publication number: 20220061370
    Abstract: This disclosure relates to methods and compositions with enhanced levels of one or more tyramine containing hydroxycinnamic acid amides. Also disclosed herein are methods for producing a consumable product with enhanced levels of a tyramine containing hydroxycinnamic acid amide. Some embodiments relate to a composition enriched with a tyramine containing hydroxycinnamic acid.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 3, 2022
    Inventors: Lee Heil CHAE, James Flatt, Alexandra Marcela Herrmann, Gabriel Navarro, Jessica Leigh Ochoa
  • TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF
    Publication number: 20190375705
    Abstract: Tyramine containing hydroxycinnamic acid amide derivatives are provided as are methods of using the same in modulating metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Application
    Filed: July 12, 2019
    Publication date: December 12, 2019
    Inventors: Lee Heil CHAE, Jessica Leigh OCHOA, Dennis SOLAS